A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels

Annals of Surgical Oncology

Volumn 8, Issue 10, 2001, Pages 779-786

  Libutti, Steven K ^a,b,d   Alexander, H Richard ^a,b   Choyke, Peter ^b,c   Bartlett, David L ^a,b   Bacharach, Stephen L ^b,c   Whatley, Millie ^b,c   Jousse, Frederic ^b,c   Eckelman, William C ^b,c   Kranda, Karen ^a,b   Neumann, Ronald D ^b,c   Carrasquillo, Jorge A ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Department of Diagnostic Radiology ^*  (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Carcinoembryonic antigen; Colon cancer recurrence; FDG; Positron emission tomography; Radioimmunoscintigraphy

Indexed keywords

ARCITUMOMAB TC 99M; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON CANCER; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; INOPERABLE CANCER; LAPAROTOMY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SECOND LOOK SURGERY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; COLONIC NEOPLASMS; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LAPAROTOMY; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RECURRENCE; SECOND-LOOK SURGERY; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 18244395371     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.10.779     Document Type: Article

References (38)

1. Cancer Statistics, 2001
2. Cancer statistics, 1999
3. Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study
4. Liver resection for colorectal metastases
5. Surgical treatment of colorectal metastases to the liver
6. Surgery for recurrent colon cancer: Strategies for identifying resectable recurrence and success rates after resection
7. Liver resection for metastatic colorectal cancer: Assessing the risk of occult irresectable disease
8. Surgery for lung metastases from colorectal cancer: Analysis of prognostic factors
9. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology
10. Carcinoembryonic antigen directed multiple surgical procedures for recurrent colon cancer confined to the liver
11. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma
12. Overview of clinical radioimmunodetection of human tumors
13. Current status of radioimmunotherapy
14. Positron emission tomography imaging of colorectal cancer
15. 18F]-FDG in oncology: A clinical update
16. Oncological applications of FDG PET imaging
17. 18F]flu orodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studies
18. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fabantibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal, phase III trial
19. Detection of pelvic recurrence of colorectal carcinoma: Prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT
20. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels
21. 18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution
22. Enhanced 3D PET OSEM reconstruction using inter-update Metz filtering
23. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver
24. Isolated hepatic perfusion: A potentially effective treatment for patients with metastatic or primary cancers confined to the liver
25. A phase 1-11 study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver
26. A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in the treatment of peritoneal carcinomatosis
27. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer
28. CEA directed second-look surgery for colon and rectal cancer
29. Technical surgical considerations for CEA directed second-look operations and hepatic tumor excision
30. PET imaging in oncology
31. MR imaging, CT and CEA scintigraphy in the diagnosis of local recurrence of rectal carcinoma
32. Anti-CEA immunoscintigraphy and computed tomographic scanning in the preoperative evaluation of mediastinal lymph nodes in lung cancer
33. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer
34. 18F]fluoro-2-deoxy-D-glucose
35. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer
36. Added value of CEA scintigraphy in the detection of recurrence of rectal carcinoma
37. Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study
38. FDG PET and immunoscintigraphy with 99mTc-labeled antibody fragments for detection of the recurrence of colorectal carcinoma